PFE

The Dow Jones – How Bad Is It?

2020-03-17

Research Articles

The Dow Jones Industrial Average is an index of 30 stocks that is often utilized as a proxy for the whole market. Since it is such a small index, I thought you all might find it interesting to see what the market looks like considering the recent volatility. Therefore, with this video I will take […]

Is the New Pfizer an Attractive Investment?

2020-02-25

Research Articles

Introduction Pharmaceutical giant Pfizer (PFE) is a company in transition that will soon be smaller but hopefully more profitable.  Since many of their established drugs are coming off patent, the company is divesting its older drug platform under the Upjohn brand and selling it to Mylan a leading generic pharmaceutical company.  Pfizer believes that this […]

10 More of 50 Fairly-Valued Dividend Growth Stocks Offering Moderately High Yields: Part 2

2018-04-10

Research Articles

Introduction This is the second of a five-part series presenting 50 dividend growth stocks that I have screened for current fair value.  With this article I will be covering 10 additional dividend growth research candidates in addition to the initial 10 that I presented in part 1 found here. Furthermore, I wanted to be clear […]

Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5

2017-10-19

Research Articles

Introduction Thus far, with the first 3 parts of this five-part series, we’ve examined 60% (18 of 30) of the 30 stocks in the Dow Jones Industrial Average.  What we found so far were that the majority of these constituents are currently overvalued or at least fully valued.  Finally, with this Part 4, we will […]

Pfizer Inc. Invest For Attractive Valuation and The 4% Dividend Yield

2017-02-22

Research Articles

Investment Thesis Pfizer Inc (PFE) is one of the world’s largest pharmaceutical firms with sales exceeding $50 billion.  The company is currently attractively valued at a blended P/E ratio of 13.3, offering a current dividend yield of 4%.  Pfizer is awarded an S&P credit rating of AA and possesses a modest debt to capital ratio […]

12 Dividend Growth Stocks That Meet My “Magic Formula for Dividend Growth Investors”

2017-02-09

Research Articles

Investing Thesis When investing for dividend growth there are several key attributes that I consider crucial for long-term success.  My definition of long-term success is first and foremost to generate a steadily-rising dividend income stream, and secondarily, the opportunity to generate a reasonable level of capital appreciation.  With this article I will present 12 dividend […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.